Actavis PLC (NYSE:ACT)

197.39
Data as of Apr 17
 -1.99 / -1.00%
Today’s Change
96.52
Today|||52-Week Range
230.77
+17.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$33.4B

Company Description

Actavis plc operates as an investment holding company. It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products. The company was founded on October 1, 2013 and is headquartered in Dublin, Ireland.

Contact Information

Actavis Plc
1 Grand Canal Square
Dublin Dublin 2
P:(951) 493-5300
Investor Relations:
(862) 261-8030

Employees

Shareholders

Mutual fund holders45.77%
Other institutional40.96%
Individual stakeholders0.46%

Top Executives

Paul M. BisaroChairman, President & Chief Executive Officer
Robert A. StewartPresident-Global Operations
Robert Todd JoyceGlobal Chief Financial Officer
James DareccaChief Accounting Officer & Vice President
Sigurdur Oli OlafssonDirector & President-Actavis Pharma

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.